Page last updated: 2024-08-17

nad and su 1498

nad has been researched along with su 1498 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berk, BC; Mathews, MT	1

Other Studies

1 other study(ies) available for nad and su 1498

Article	Year
PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2. Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:4 Topics: Adenosine Triphosphate; Apoptosis; Cell Death; Cells, Cultured; Cinnamates; Endothelial Cells; Enzyme Inhibitors; Humans; NAD; Nitrosation; Oxidation-Reduction; Oxidative Stress; Phenanthrenes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Reactive Nitrogen Species; RNA, Small Interfering; Transcriptional Activation; Vascular Endothelial Growth Factor Receptor-2	2008

Article

Year

PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2.

Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:4

Topics: Adenosine Triphosphate; Apoptosis; Cell Death; Cells, Cultured; Cinnamates; Endothelial Cells; Enzyme Inhibitors; Humans; NAD; Nitrosation; Oxidation-Reduction; Oxidative Stress; Phenanthrenes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Reactive Nitrogen Species; RNA, Small Interfering; Transcriptional Activation; Vascular Endothelial Growth Factor Receptor-2

2008